<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="81987">
  <stage>Registered</stage>
  <submitdate>26/04/2007</submitdate>
  <approvaldate>3/05/2007</approvaldate>
  <actrnumber>ACTRN12607000236493</actrnumber>
  <trial_identification>
    <studytitle>High energy diets and airway inflammation</studytitle>
    <scientifictitle>Using high energy diets to induce inflammation in asthma</scientifictitle>
    <utrn />
    <trialacronym>FAT</trialacronym>
    <secondaryid>Nil Known</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Asthma</healthcondition>
    <healthcondition>Healthy Controls</healthcondition>
    <conditioncode>
      <conditioncode1>Respiratory</conditioncode1>
      <conditioncode2>Asthma</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>The second phase of the study intervention is a 4hour dietary challenge model instead of the 24hr dietary challenge model previously identified.The study will be a randomised ,controlled, single blinded, parallel trial with 3 groups, each using a 4 hour dietary challenge of an equicaloric meal of varying macro nutrient composition.In each group the participants will receive one meal consisting of 800 calories</interventions>
    <comparator>Control = Low energy diet (75% Recommended Daily Energy Intake). </comparator>
    <control>Dose comparison</control>
    <interventioncode>Other interventions</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Plasma IL-6, assessed by Enzyme Immuno Assay</outcome>
      <timepoint>At 0, 4 and 24 hours</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Sputum neutrophils</outcome>
      <timepoint>Assessed by differential cell count at 0,4 and 24 hours</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Adults with asthma and healthy controls</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Abnormal blood pressure- Abnormal heart rhythms- Abnormal blood cholesterol levels- Obesity (Body Mass Index (BMI) &gt;30)- History of coronary heart disease, diabetes or familial lipid disorders- Use of blood pressure or lipid-lowering drugs or oral corticosteroids.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>After screening for eligibility, subjects will be assigned to the next available study number which has previously been randomly allocated to the Intervention or Control group. Allocation will be concealed until the clinical research officer contacts the holder of the allocation schedule at a central administration site.</concealment>
    <sequence>Computer generated sequence</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 1</phase>
    <anticipatedstartdate>9/05/2007</anticipatedstartdate>
    <actualstartdate>8/02/2007</actualstartdate>
    <anticipatedenddate />
    <actualenddate>2/02/2010</actualenddate>
    <samplesize>34</samplesize>
    <actualsamplesize>129</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
    <hospital>John Hunter Hospital Royal Newcastle Centre - New Lambton</hospital>
    <postcode>2305 - New Lambton Heights</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Government body</primarysponsortype>
    <primarysponsorname>Hunter New England Health Service</primarysponsorname>
    <primarysponsoraddress>Lookout Rd, New Lambton Heights, 2305, NSW, Australia</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>John Hunter Hospital Charitable Trust Fund</fundingname>
      <fundingaddress>Lookout Rd, New Lambton Heights, 2305, NSW, Australia</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>none</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This study examines the effect of a high energy intake on inflammation in asthma. We hypothesise that a high energy diet will cause an increase in both systemic and airway inflammation. Subjects are randomly assigned to a high energy or low energy diet for 24 hours. Systemic and airway inflammation will be assessed at 0, 4 and 24 hours.</summary>
    <trialwebsite />
    <publication>1.	Wood LG, Garg ML, Gibson PG. A high-fat challenge increases airway inflammation and impairs bronchodilator recovery in asthma. J Allergy Clin Immunol 2011; 127(5): 1133-40.
2.	Wood LG, Garg ML, Wood A, Smart J, Gibson PG. A High Fat, High Energy Food Challenge Induces an Exaggerated Inflammatory Response in Asthma. Am J Respir Crit Care Med 2009; 179.
3.	Haghi M, Chrzanowski W, Traini D, Wood LG, Oliver B, Young PM A soft spot for drug transport: modulation of cell stiffness using fatty acids and its impact on drug transport in a lung model. Journal of Materials Chemistry B 3: 258/3-89 (2015).
4.	De Pedro M, Wood L, Oliver B. THE EFFECT OF FATTY ACIDS ON B2-AGONIST RESPONSE IN HUMAN AIRWAY SMOOTH MUSCLE CELLS. Respirology 2014; 19: 64
5.	Haghi M, Chrzanowski W, Traini D, Wood L, Oliver B, Young P. THE ROLE OF DIETARY FATTY ACIDS IN TRANSPORT OF SALBUTAMOL ACROSS CALU-3 EPITHELIA. Respirology 2014; 19: 38
</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>John Hunter Hospital-University of Newcastle</ethicname>
      <ethicaddress />
      <ethicapprovaldate>13/12/2007</ethicapprovaldate>
      <hrec>06/10/25/5.03</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>A/Prof</title>
      <name>Dr Lisa Wood</name>
      <address>Centre for Asthma and Respiratory Diseases
Level 2, West Wing, HMRI Building
Kookaburra Crt
New Lambton Heights, NSW, 2305
</address>
      <phone>+61 2 40420147</phone>
      <fax>+61 2 40420046</fax>
      <email>lisa.wood@newcastle.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Bronwyn Berthon</name>
      <address>Centre for Asthma and Respiratory Diseases
Level 2, West Wing, HMRI Building
Kookaburra Crt
New Lambton Heights, NSW, 2305
</address>
      <phone>+61 2 40420116</phone>
      <fax>+61 2 40420046</fax>
      <email>bronwyn.berthon@newvcastle.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Bronwyn Berthon</name>
      <address>Centre for Asthma and Respiratory Diseases
Level 2, West Wing, HMRI Building
Kookaburra Crt
New Lambton Heights, NSW, 2305
</address>
      <phone>+61 2 40420116</phone>
      <fax>+61 2 40420046</fax>
      <email>bronwyn.berthon@newcastle.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Lisa Wood</name>
      <address>Centre for Asthma and Respiratory Diseases
Level 2, West Wing, HMRI Building
Kookaburra Crt
New Lambton Heights, NSW, 2305

</address>
      <phone>+61 2 40420147</phone>
      <fax>+61 2 40420046</fax>
      <email>lisa.wood@newcastle.edu.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>